Cytosorbents top shareholders
WebOct 10, 2024 · Hedge funds don't have many shares in Cytosorbents. The company's largest shareholder is Robert Shipley, with ownership of 6.5%. With 6.1% and 4.9% of the shares outstanding respectively,... WebThe company is committed to serving the best interests of our patients and their families, our customers, our employees, and our shareholders. Are you an Investor? CytoSorb® is a unique blood purification therapy.The product is currently approved in the European Union and distributed in 58 countries around the world Are you a Healthcare Provider?
Cytosorbents top shareholders
Did you know?
WebCytosorbents Corp annual reports of executive compensation and pay are most commonly found in the Def 14a documents. Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year. WebApr 4, 2024 · Of the 39 institutional investors that sold Cytosorbents stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: …
WebFeb 21, 2024 · However, when several insiders are buying, like in the case of Cytosorbents Corporation (NASDAQ:CTSO), it sends a favourable message to the company's shareholders. WebApr 29, 2024 · CytoSorbents Contact: Amy Vogel Investor Relations (732) 398-5394 [email protected] Investor Relations Contact: Jeremy Feffer LifeSci Advisors (212) 915-2568 [email protected]...
Web22 hours ago · By Colin Kellaher. April 13, 2024 10:04 am ET. Text. Groupon Inc. on Thursday said it named Jiri Ponrt as its chief financial officer, as the biggest shareholder … WebJan 12, 2024 · MONMOUTH JUNCTION, N.J., Jan. 12, 2024 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO ), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology...
WebApr 7, 2024 · Cytosorbents Corp’s trailing 12-month revenue is $36.1 million with a -114.6% profit margin. Year-over-year quarterly sales growth most recently was -17.3%. Analysts expect adjusted earnings to reach $-0.374 per share for the current fiscal year. Cytosorbents Corp does not currently pay a dividend. There is a positive fundamental …
WebThe company is committed to serving the best interests of our patients and their families, our customers, our employees, and our shareholders. Are you an Investor? CytoSorb® … port harcourt floodingWeb2 days ago · SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harmony Biosciences Holdings, Inc. - HRMY Published: April 12, 2024 at … irisin hormone where to buy ukWeb23 hours ago · April 13, 2024 09:14 AM updated an hour ago. Reuters. MILAN - Stellantis shareholders on Thursday approved the compensation package for the car maker's top … port harcourt electricity distributionWeb1 day ago · The investment firm has sold $7.2 billion worth of TCEHY as of January. TCEHY stock is up by about 1.5% year-to-date. Source: StreetVJ / Shutterstock.com. Shares of … irisin supplement reviewsWebJan 29, 2024 · A look at the shareholders of Cytosorbents Corporation ( NASDAQ:CTSO ) can tell us which group is most powerful. We can... irisity rapporterWebApr 12, 2024 · Cytosorbents issued an update on its fourth quarter 2024 earnings guidance on Tuesday, January, 31st. The company provided earnings per share guidance of for … port harcourt country of birth nigeriaWebApr 27, 2015 · MONMOUTH JUNCTION, N.J., April 24, 2015 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy company commercializing its European Union approved CytoSorb® blood filter to treat deadly inflammation in critically-ill and cardiac surgery patients, issued a letter to its … irisity ab